Differentiating Approach to Acne Therapy: Women vs. Men
Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.
Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.
FACULTY
Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY
Julie C. Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham
Birmingham, Alabama
Watch Now
You May Also Like
Did You Miss These? Missed any of our recent Video Abstracts? Catch up now! A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a…
Botulinum Toxin for Hidradenitis Suppurativa? Early Evidence Looks Promising Hidradenitis suppurativa (HS) remains a challenging and often painful condition—one that disproportionately affects women, people of color, and underserved populations. With…
Author Spotlight: Dr. Natalia Neha Khosla on Health Equity, Inflammation, and Innovation in Dermatology July’s JDD Author Spotlight features Natalia Neha Khosla, MD MSc, author of the July article, “Socioeconomic…
